[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540587":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":22,"responsibleParty":40,"collaborators":7,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",null,[9,11],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"three-phase CT angiography",{"type":6,"name":12,"description":12,"armGroupLabels":7,"otherNames":7},"CEUS ultrasound",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Thierry REIX, Pr","CONTACT","03.22.08.72.65","reix.thierry@chu-amiens.fr",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},"Gabriel IFERGAN, Dr","ifergan.gabriel@chu-amiens.fr",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"CHU Amiens Picardie","RECRUITING","Amiens","Picardie","80054","France",{"type":31,"coordinates":32},"Point",[33,34],2.3,49.9,{"lat":34,"lon":33},[37],{"name":38,"role":16,"phone":39,"phoneExt":7,"email":18},"Thierry REIX, PhD","+33322455929",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100540587",false,"NCT06318780","Concordance of Three Imaging Methods by Dynamic CT, Contrast Ultrasound and CT Angiography in the Characterization of Endoleaks in Patients With an Aortic Endoprosthesis","LEAKDYN","Inclusion Criteria:\n\n* Patients 18 years of age and older,\n* Patients who have received EVAR ,\n* Detection of endoleak and\u002For with an aneurysmal sac enlargement greater than or equal to 5 mm over 6 months.\n\nExclusion Criteria:\n\n* Minor patients,\n* absence of endoleak and growth of the aneurysmal sac (greater than or equal to 5 mm over 6 months),\n* patient under guardianship, curators, safeguard of justice,\n* patient deprived of liberty,\n* pregnant woman\n* Patient who does not benefit from a social security scheme","ALL","18 Years",{"count":51,"type":52},69,"ESTIMATED","INTERVENTIONAL",[55],"NA","Among patients who have undergone EVAR, there is a significant risk of 20-50% endoleak. These endoleaks often require secondary interventions to reduce the risk of expansion or rupture. Currently, three-phase CT angiography and CEUS ultrasound are recommended in the post-operative monitoring of EVAR but these remain limited in characterizing the type and source of endoleak. In this study the investigators will study the interest of d-CTA for a better detection and characterization of endoleaks.",[58],"Aortic Diseases",[60,61,62],"EVAR","d-CTA","CEUS","2025-05-21",{"date":65,"type":66},"2025-05-25","ACTUAL",{"date":68,"type":66},"2024-02-28",{"date":70,"type":52},"2031-02",{"name":5,"class":6},1]